Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122074) titled 'Efficacy and Economic Impact of Venetoclax for Leukocytosis During Induction Therapy in Acute Promyelocytic Leukemia (APL)' on April 8.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Linyi People's Hospital
Condition:
acute promyelocytic leukemia,APL
Intervention:
experimental group:Ven reduces white blood cells.
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-01-04
Target Sample Size: experimental group:40;control group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=308649
Published by HT D...